Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity ...Middle East

Longevity Biomedical is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase health span for the rapidly growing global aging...

Hence then, the article about longevity biomedical inc and denali capital acquisition corp announce business combination to create nasdaq listed biopharmaceutical company focused on advancing new technologies to promote human health and longevity was published today ( Thursday 26/01/2023 - 02:44 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity )

Also on site :

• A Recent Tragedy Has Left My Kids Devastated. But I’m Secretly Pleased.
• Watch last video of ‘All That’ star Kianna Underwood who died in hit-and-run at 33
• Refugee-student housing project in EU state rocked by rape scandal